Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors - Image 1

£83.40

Academic Press Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors

Name: Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors
Brand: Academic Press
Price: 83.4 GBP
Availability: InStock

Illnesses & Conditions

It has never been this cheap. We have no record of a lower price.

£83 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 78 days · 78 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 78 days • 5 price levels

Days at Price

Current Price

Price Analysis

Most common price: £85 (47 days, 60.3%)

Price range: £83 - £90

Price levels: 5 different prices over 78 days

Description

Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors explores trace amines which, under normal conditions, are present in the mammalian brain and peripheral nervous tissues at very low (nanomolar) concentrations. However, in a diverse array of human pathologies ranging from substance abuse, depression, attention deficit hyperactivity disorder, eating disorders, schizophrenia, and other neurological and neuropsychiatric diseases, the levels of trace amines are unusually high with an imbalance in their functions. Furthermore, the rapid turnover of trace amines is evidenced by their dramatic increases following treatment with monoamine oxidase inhibitors (MAOI) or deletion of the MAO genes. This suggests that the concentration of trace amines may be considerably higher at neuronal synapses than predicted by steady-state measures, implicating some pathophysiological role. Therefore, understanding molecular mechanisms and developing selective agonists and antagonists for trace amine-associated receptors (TAARs) has become a good approach for treating these diseases. Although the effects of trace amines at low physiological concentrations in mammalian species have been difficult to demonstrate, they may serve to maintain the neuronal activity of other monoamine neurotransmitters by possessing postsynaptic modulatory effects, particularly dopamine and serotonin, within defined physiological limits. Such an effect of trace amines makes them ideal candidates for the development of novel therapeutics for a wide range of human disorders. This book presents up-to-date, cutting-edge, and comprehensive information on the link between trace amines and neurological disorders. * Focuses on recent findings on trace amines, providing insights into the functional significance, molecular mechanisms, and biological relevance of TAARS in neurological disorders* Edited work with chapters authored by leaders in the field from around the globe, the broadest, most expert coverage available* Provides cutting-edge research on trace amines-mediated signaling in vertebrate model systems

Product Specifications

Brand: Academic Press
Format: hardcover
ASIN: 0128036036
Category: Books > Subjects > Health, Family & Lifestyle > Health Issues > Illnesses & Conditions
Domain: Amazon UK
Release Date: 01 August 2016
Listed Since: 02 May 2016

Barcode

No barcode data available

Academic Press Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)

Attention-Deficit/Hyperactivity Disorder and the Hyperkinetic Syndrome: Current Ideas and Ways Forward

Behavioral Neurogenomics: 42 (Current Topics in Behavioral Neurosciences, 42)

5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

Wiley Chemical Biology of Neurodegeneration - Molecular Approach

Neurotoxin Modeling of Brain Disorders ― Life-long Outcomes in Behavioral Teratology: 29 (Current Topics in Behavioral Neurosciences, 29)

Ketamine for Treatment-Resistant Depression: The First Decade of Progress

Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)

Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks

Academic Press Handbook of Behavioral Neurobiology of Serotonin

Neurophenotypes: Advancing Psychiatry and Neuropsychology in the "OMICS" Era (Innovations in Cognitive Neuroscience)

Neuropsychopharmacology: 64 (Journal of Neural Transmission. Supplementa, 64)

Dopamine (Volume 211) (Progress in Brain Research, Volume 211)

Drug Discovery for Psychiatric Disorders: Volume 28 (Drug Discovery Series)

Dopamine Receptor Technologies: 96 (Neuromethods, 96)

Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance (Progress in Brain Research): 172

Academic Press Serotonin: The Mediator That Spans Evolution

Massachusetts General Hospital Psychopharmacology and Neurotherapeutics

Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)